Cote d'Ivoire vs Sudan: Treatment coverage for schistosomiasis
Cote d'Ivoire
27.2%
in 2024
Sudan
35.1%
in 2022
Cote d'Ivoire rank
38th
Sudan rank
37th
Treatment coverage for schistosomiasis over time
- Cote d'Ivoire
- Sudan
How they compare
Sudan currently reports 35.1% against 27.2% in Cote d'Ivoire, a difference of 7.9%.
That makes Sudan's figure about 1.3 times Cote d'Ivoire's.
The two have swapped places 7 times across 10 shared years of data; in 2009 it was Sudan ahead.
Cote d'Ivoire ranks 38th and Sudan ranks 37th of 45 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 2 and Sudan in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 3.0% | 3.0% | Sudan |
| 2010s | 37.2% | 31.1% | 6.2% | Cote d'Ivoire |
| 2020s | 40.9% | 35.1% | 5.7% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cote d'Ivoire or Sudan?
- Sudan, at 35.1% against 27.2% in Cote d'Ivoire as of 2022.
- What is the difference in treatment coverage for schistosomiasis between Cote d'Ivoire and Sudan?
- 7.9%, with Sudan ahead.
- How many years of comparable data are there for Cote d'Ivoire and Sudan?
- 10 years are reported by both, from 2009 to 2022.
- How do Cote d'Ivoire and Sudan rank globally for treatment coverage for schistosomiasis?
- Cote d'Ivoire ranks 38th and Sudan ranks 37th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.